Target type: biologicalprocess
Any process that modulates the rate, frequency or extent of cell adhesion molecule production. Cell adhesion molecule production is the appearance of a cell adhesion molecule as a result of its biosynthesis or a decrease in its catabolism. [GOC:BHF, GOC:rl]
The regulation of cell adhesion molecule (CAM) production is a complex process involving multiple signaling pathways and transcription factors. These molecules mediate cell-cell and cell-extracellular matrix interactions, playing crucial roles in development, tissue morphogenesis, wound healing, and immune responses.
**Transcriptional regulation:**
* **Signal transduction pathways:**
* **Integrin signaling:** Integrins, transmembrane receptors that bind to extracellular matrix components, activate intracellular signaling pathways like the focal adhesion kinase (FAK) and Src pathways, leading to the activation of transcription factors such as AP-1, NF-κB, and STATs.
* **Growth factor signaling:** Growth factors like EGF, TGF-β, and VEGF activate their respective receptors, triggering downstream signaling cascades that ultimately regulate CAM gene expression.
* **Cytokine signaling:** Cytokines, such as TNF-α and IL-1β, activate signaling pathways that regulate CAM expression, often leading to changes in cell adhesion and migration.
* **Transcription factors:**
* **AP-1:** A heterodimer of Jun and Fos proteins, AP-1 is activated by various signaling pathways and directly binds to promoter regions of CAM genes.
* **NF-κB:** Activated by stress signals and cytokines, NF-κB controls the expression of various CAMs, contributing to inflammation and immune responses.
* **STATs:** Activated by cytokine receptors, STATs translocate to the nucleus and regulate the expression of CAMs involved in immune responses and cell migration.
* **Epigenetic modifications:**
* **DNA methylation:** Changes in DNA methylation patterns can influence the accessibility of CAM gene promoters, affecting their expression.
* **Histone modifications:** Post-translational modifications of histones, such as acetylation and methylation, can alter chromatin structure and regulate CAM gene expression.
**Post-translational regulation:**
* **Glycosylation:** CAMs undergo extensive glycosylation, which can influence their binding affinity and interactions with other molecules.
* **Proteolytic processing:** Some CAMs are proteolytically cleaved, releasing soluble fragments that can act as signaling molecules or modulate cell adhesion.
* **Phosphorylation:** Phosphorylation of CAMs can regulate their activity, localization, and interactions with other proteins.
**Regulation of CAM expression is highly dynamic and context-dependent. It is tightly controlled by cellular signaling pathways, transcription factors, and post-translational modifications. Understanding this complex regulatory network is crucial for developing therapeutic strategies for diseases involving dysregulated cell adhesion, such as cancer, inflammation, and developmental disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
Alpha-(1,3)-fucosyltransferase 7 | An alpha-(1,3)-fucosyltransferase 7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q11130] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
2,3-dihydroxybenzoic acid | 2,3-dihydroxybenzoic acid : A dihydroxybenzoic acid that is benzoic acid substituted by hydroxy groups at positions 2 and 3. It occurs naturally in Phyllanthus acidus and in the aquatic fern Salvinia molesta. 2,3-dihydroxybenzoic acid: RN given refers to parent cpd dihydroxybenzoic acid : Any member of the class of hydroxybenzoic acids carrying two phenolic hydroxy groups on the benzene ring and its derivatives. | dihydroxybenzoic acid | human xenobiotic metabolite; plant metabolite |
protocatechuic acid | 3,4-dihydroxybenzoic acid : A dihydroxybenzoic acid in which the hydroxy groups are located at positions 3 and 4. protocatechuic acid: RN given refers to parent cpd; structure | catechols; dihydroxybenzoic acid | antineoplastic agent; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; human xenobiotic metabolite; plant metabolite |
gallic acid | gallate : A trihydroxybenzoate that is the conjugate base of gallic acid. | trihydroxybenzoic acid | antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite |
beta-resorcylic acid | beta-resorcylic acid: RN given refers to parent cpd; structure | ||
2,5-dihydroxybenzoic acid | 2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions. 2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin | dihydroxybenzoic acid | EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; fungal metabolite; human metabolite; MALDI matrix material; mouse metabolite |
veratric acid | 3,4-dimethoxybenzoic acid : A member of the class of benzoic acids that is benzoic acid substituted by methoxy groups at positions 2 and 3. veratric acid: RN given refers to parent cpd; structure | benzoic acids | allergen; plant metabolite |
methyl gallate | methyl 3,4,5-trihydroxybenzoate : A gallate ester obtained by the formal condensation of gallic acid with methanol. It exhibits anti-oxidant, anti-tumor, anti-microbial and anti-inflammatory properties. methyl gallate: has both immunosuppressive and phytogenic antineoplastic activities; isolated from Acer saccharinum | gallate ester | anti-inflammatory agent; antioxidant; plant metabolite |
3,4,5-trimethoxybenzoic acid | 3,4,5-trimethoxybenzoic acid : A benzoic acid derivative carrying 3-, 4- and 5-methoxy substituents. 3,4,5-trimethoxybenzoic acid: RN given refers to parent cpd; structure | benzoic acids; methoxybenzenes | human urinary metabolite; human xenobiotic metabolite; plant metabolite |
syringic acid | syringic acid : A dimethoxybenzene that is 3,5-dimethyl ether derivative of gallic acid. syringic acid: RN given refers to parent cpd; structure in third source | benzoic acids; dimethoxybenzene; phenols | plant metabolite |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
guanosine diphosphate | Guanosine Diphosphate: A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. | guanosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor |